Related Experiment Video
Updated: Mar 2, 2026

Measuring Ascending Aortic Stiffness In Vivo in Mice Using Ultrasound
Published on: December 2, 2014
Associations between glycaemic deterioration and aortic stiffness and central blood pressure: the ADDITION-PRO Study
Nanna B Johansen1, Signe S Rasmussen, Niels Wiinberg
1aResearch Centre for Prevention and Health, Centre for Health, Capital Region of Denmark, Glostrup bSteno Diabetes Center Copenhagen, Gentofte cDanish Diabetes Academy, Odense dDepartment of Cardiology, Nephrology and Endocrinology, Nordsjællands Hospital, Hillerød eDepartment of Clinical Physiology, Frederiksberg Hospital, Frederiksberg fDepartment of Medical Research, Holstebro Hospital and University of Aarhus, Holstebro gDepartment of Public Health, Section of General Practice, Faculty of Health Sciences, Aarhus University, Aarhus, Denmark.
Insights
Diabetes risk impacts aortic stiffness. Higher HbA1c at screening correlated with increased aortic stiffness (aPWV) and lower central diastolic blood pressure (DBP). Glycemic changes over time did not independently affect these measures.
Area of Science:
- Cardiovascular disease research
- Metabolic disorders and diabetes
- Public health screening programs
Background:
- Diabetes risk assessment is crucial for early intervention.
- Central hemodynamics, including aortic stiffness and central blood pressure, are key indicators of cardiovascular health.
- Understanding the relationship between glycemic control and hemodynamic parameters is vital for managing diabetes complications.
Purpose of the Study:
- To investigate central hemodynamic profiles across different diabetes risk strata.
- To analyze the association of glycated hemoglobin A1c (HbA1c) levels and changes with central hemodynamics.
- To evaluate the impact of diabetes risk screening on cardiovascular health markers.
Main Methods:
- A Danish population-based screening program identified seven diabetes risk groups.
- Follow-up included 2048 individuals assessed for aortic stiffness (aPWV) and central blood pressure (BP) after 7.8 years.
- Statistical analyses adjusted for confounders to examine HbA1c and its changes' impact on hemodynamics.
Main Results:
- Individuals with high diabetes risk scores and impaired glucose tolerance exhibited higher aortic stiffness (aPWV), central systolic BP (SBP), diastolic BP (DBP), and pulse pressure.
- A 1% point increase in screening HbA1c was linked to a 0.23 m/s increase in aPWV and a 1.35 mmHg decrease in central DBP.
- Glycemic deterioration over the follow-up period showed no independent association with central hemodynamics.
Conclusions:
- Dysglycemia, particularly at screening, is associated with increased future aortic stiffness.
- While initial HbA1c levels influence central hemodynamics, glycemic changes over time do not independently predict aortic stiffness or central BP.
- These findings highlight the importance of baseline glycemic status in assessing cardiovascular risk.
Objectives:
In the context of screening for diabetes, we examined levels of central haemodynamics among individuals with different levels of diabetes risk and analysed the impact of glycated haemoglobin A (HbA1c) and HbA1c changes on central haemodynamics.
Methods:
A Danish population-based stepwise screening programme for diabetes including a diabetes risk score (DRS) questionnaire and glucose measurements identified seven groups of individuals at increasing levels of diabetes risk. After 7.8 years of follow-up, 2048 individuals underwent aortic stiffness assessment by carotid-femoral pulse wave velocity (aPWV) and assessment of central blood pressure (BP). We compared differences in central haemodynamics at follow-up between the diabetes risk groups and analysed the impact of HbA1c at screening and HbA1c change on central haemodynamics at follow-up adjusting for relevant confounders.
Results:
At screening, median age was 59.0 years, and median HbA1c was 5.7%. At follow-up, median aPWV was 8.0 m/s, and median central SBP was 123.5 mmHg. Among individuals with high DRS, aPWV, central SBP and DBP, and pulse pressure were higher in individuals with impaired glucose tolerance than normal glucose tolerance. Per 1%-point higher HbA1c at screening, aPWV was 0.23 m/s (95% confidence interval: 0.00; 0.46) higher, and central DBP was 1.35 mmHg (95% confidence interval: 0.19; 2.51) lower, whereas HbA1c change was not associated with any of the central haemodynamics.
Conclusion:
Dysglycaemia is associated with future aortic stiffness. However, glycaemic deterioration over 7.8 years does not affect aortic stiffness or central BP independently of other cardiometabolic risk factors.
Related Concept Videos
Coronary Artery Disease I: Introduction
Atherosclerosis II: Clinical Manifestations and Diagnostic Tests
Hypertension III: Clinical Manifestations and Diagnostic Studies
Peripheral Arterial Disease II: Clinical Manifestations and Diagnostic Evaluation
Factors affecting Blood pressure
Physiological Factors:
Hypertension II: Pathophysiology

